Long-term results of Gamma Knife surgery for uveal melanomas.

Dong Wan Kang, Sungchul Lee, Yong Gou Park, Jong Hee Chang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality in the treatment of uveal melanomas. It could be used as an alternative treatment to enucleation, preserving the eyeball as well as visual function. The authors report their experiences with GKS for uveal melanomas for the period from February 1998 to December 2006. Twenty-two patients with uveal melanoma were enrolled in this study. The population consisted of 12 men and 10 women with a mean age of 53.4 years (range 24-79 years). The mean tumor volume was 877 mm(3), and the mean margin dose was 45.6 Gy. The median follow-up period was 67 months (range 3-126 months). All of the patients had received a diagnosis and referral from an ophthalmology clinic; the patients underwent a preoperative orbital examination that included MRI. Tumor regression was achieved in 20 patients (90.9%), whereas tumor progression was observed in 2 patients (9.1%) 3 years after GKS. The cumulative 1-year and 2-year mean rates of tumor thickness reduction were 18.8% and 42.8%, respectively. The mean rate of tumor volume reduction was 63.7%. The rate of eye retention 5 years after radiosurgery was 77.3% (17 of 22 patients). Overall visual acuity was reduced after GKS in all patients; 14 patients (63.6%) displayed preserved visual function better than hand-movement perception. The most frequent side effect was cataract, which was detected in 9 patients (40.9%); this was followed in frequency by radiation-induced retinopathy in 5 patients (22.7%). Gamma Knife surgery provides excellent local control of uveal melanomas with a decrease in volume over time. This procedure not only preserves the eyeball and its potential visual function, but also decreases the potential for hematological dissemination and achieves sufficient local tumor control with a gradual reduction in volume.

Original languageEnglish
Pages (from-to)108-114
Number of pages7
JournalJournal of Neurosurgery
Volume117 Suppl
Publication statusPublished - 2012 Jan 1

Fingerprint

Tumor Burden
Neoplasms
Uveal melanoma
Radiosurgery
Ophthalmology
Cataract
Visual Acuity
Referral and Consultation
Hand
Radiation
Therapeutics
Population

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Kang, D. W., Lee, S., Park, Y. G., & Chang, J. H. (2012). Long-term results of Gamma Knife surgery for uveal melanomas. Journal of Neurosurgery, 117 Suppl, 108-114.
Kang, Dong Wan ; Lee, Sungchul ; Park, Yong Gou ; Chang, Jong Hee. / Long-term results of Gamma Knife surgery for uveal melanomas. In: Journal of Neurosurgery. 2012 ; Vol. 117 Suppl. pp. 108-114.
@article{993d05aa533d48fd9f795bfdc702cf2b,
title = "Long-term results of Gamma Knife surgery for uveal melanomas.",
abstract = "Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality in the treatment of uveal melanomas. It could be used as an alternative treatment to enucleation, preserving the eyeball as well as visual function. The authors report their experiences with GKS for uveal melanomas for the period from February 1998 to December 2006. Twenty-two patients with uveal melanoma were enrolled in this study. The population consisted of 12 men and 10 women with a mean age of 53.4 years (range 24-79 years). The mean tumor volume was 877 mm(3), and the mean margin dose was 45.6 Gy. The median follow-up period was 67 months (range 3-126 months). All of the patients had received a diagnosis and referral from an ophthalmology clinic; the patients underwent a preoperative orbital examination that included MRI. Tumor regression was achieved in 20 patients (90.9{\%}), whereas tumor progression was observed in 2 patients (9.1{\%}) 3 years after GKS. The cumulative 1-year and 2-year mean rates of tumor thickness reduction were 18.8{\%} and 42.8{\%}, respectively. The mean rate of tumor volume reduction was 63.7{\%}. The rate of eye retention 5 years after radiosurgery was 77.3{\%} (17 of 22 patients). Overall visual acuity was reduced after GKS in all patients; 14 patients (63.6{\%}) displayed preserved visual function better than hand-movement perception. The most frequent side effect was cataract, which was detected in 9 patients (40.9{\%}); this was followed in frequency by radiation-induced retinopathy in 5 patients (22.7{\%}). Gamma Knife surgery provides excellent local control of uveal melanomas with a decrease in volume over time. This procedure not only preserves the eyeball and its potential visual function, but also decreases the potential for hematological dissemination and achieves sufficient local tumor control with a gradual reduction in volume.",
author = "Kang, {Dong Wan} and Sungchul Lee and Park, {Yong Gou} and Chang, {Jong Hee}",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "117 Suppl",
pages = "108--114",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",

}

Kang, DW, Lee, S, Park, YG & Chang, JH 2012, 'Long-term results of Gamma Knife surgery for uveal melanomas.', Journal of Neurosurgery, vol. 117 Suppl, pp. 108-114.

Long-term results of Gamma Knife surgery for uveal melanomas. / Kang, Dong Wan; Lee, Sungchul; Park, Yong Gou; Chang, Jong Hee.

In: Journal of Neurosurgery, Vol. 117 Suppl, 01.01.2012, p. 108-114.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term results of Gamma Knife surgery for uveal melanomas.

AU - Kang, Dong Wan

AU - Lee, Sungchul

AU - Park, Yong Gou

AU - Chang, Jong Hee

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality in the treatment of uveal melanomas. It could be used as an alternative treatment to enucleation, preserving the eyeball as well as visual function. The authors report their experiences with GKS for uveal melanomas for the period from February 1998 to December 2006. Twenty-two patients with uveal melanoma were enrolled in this study. The population consisted of 12 men and 10 women with a mean age of 53.4 years (range 24-79 years). The mean tumor volume was 877 mm(3), and the mean margin dose was 45.6 Gy. The median follow-up period was 67 months (range 3-126 months). All of the patients had received a diagnosis and referral from an ophthalmology clinic; the patients underwent a preoperative orbital examination that included MRI. Tumor regression was achieved in 20 patients (90.9%), whereas tumor progression was observed in 2 patients (9.1%) 3 years after GKS. The cumulative 1-year and 2-year mean rates of tumor thickness reduction were 18.8% and 42.8%, respectively. The mean rate of tumor volume reduction was 63.7%. The rate of eye retention 5 years after radiosurgery was 77.3% (17 of 22 patients). Overall visual acuity was reduced after GKS in all patients; 14 patients (63.6%) displayed preserved visual function better than hand-movement perception. The most frequent side effect was cataract, which was detected in 9 patients (40.9%); this was followed in frequency by radiation-induced retinopathy in 5 patients (22.7%). Gamma Knife surgery provides excellent local control of uveal melanomas with a decrease in volume over time. This procedure not only preserves the eyeball and its potential visual function, but also decreases the potential for hematological dissemination and achieves sufficient local tumor control with a gradual reduction in volume.

AB - Gamma Knife surgery (GKS) is currently believed to be a safe and minimally invasive modality in the treatment of uveal melanomas. It could be used as an alternative treatment to enucleation, preserving the eyeball as well as visual function. The authors report their experiences with GKS for uveal melanomas for the period from February 1998 to December 2006. Twenty-two patients with uveal melanoma were enrolled in this study. The population consisted of 12 men and 10 women with a mean age of 53.4 years (range 24-79 years). The mean tumor volume was 877 mm(3), and the mean margin dose was 45.6 Gy. The median follow-up period was 67 months (range 3-126 months). All of the patients had received a diagnosis and referral from an ophthalmology clinic; the patients underwent a preoperative orbital examination that included MRI. Tumor regression was achieved in 20 patients (90.9%), whereas tumor progression was observed in 2 patients (9.1%) 3 years after GKS. The cumulative 1-year and 2-year mean rates of tumor thickness reduction were 18.8% and 42.8%, respectively. The mean rate of tumor volume reduction was 63.7%. The rate of eye retention 5 years after radiosurgery was 77.3% (17 of 22 patients). Overall visual acuity was reduced after GKS in all patients; 14 patients (63.6%) displayed preserved visual function better than hand-movement perception. The most frequent side effect was cataract, which was detected in 9 patients (40.9%); this was followed in frequency by radiation-induced retinopathy in 5 patients (22.7%). Gamma Knife surgery provides excellent local control of uveal melanomas with a decrease in volume over time. This procedure not only preserves the eyeball and its potential visual function, but also decreases the potential for hematological dissemination and achieves sufficient local tumor control with a gradual reduction in volume.

UR - http://www.scopus.com/inward/record.url?scp=84873316679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873316679&partnerID=8YFLogxK

M3 - Article

C2 - 23205797

AN - SCOPUS:84873316679

VL - 117 Suppl

SP - 108

EP - 114

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

ER -